Position in HROW
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$593,884
-$1,587,841 QoQ
Shares Held
16,843
-62.2% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Derivatives in HROW
reported options exposure · as of Mar 31, 2024CallValue
$164,052
CallShares
12,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. HROW ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
154,970 | $4,667,696 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
188,802 | $4,659,633 | |
| 3 | CRON |
Cronos Group Inc.
|
1,500,000 | $3,765,000 | |
| 4 | LQDA |
Liquidia Corp
|
40,595 | $1,532,055 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,345 | $1,390,538 | |
| 6 | VTRS |
Viatris Inc
|
102,186 | $1,380,532 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
50,735 | $1,146,611 | |
| 8 | ALKS |
Alkermes plc.
|
16,928 | $598,574 |
All Filings in HROW
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $593,884 | 16,843 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,181,725 | 44,525 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,655,127 | 34,353 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,857,595 | 60,825 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,661,968 | 62,480 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $1,250,945 | 37,286 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,212,031 | 26,958 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $2,197,816 | 105,209 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $164,052 | 12,400 | Call | Other | 2024-05-15 | |
| 2024-03-31 | $1,457,403 | 110,159 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $1,038,788 | 92,749 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $215,550 | 15,000 | Call | Other | 2023-11-14 | |
| 2023-09-30 | $1,289,578 | 89,741 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $884,522 | 46,456 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $924,755 | 43,703 | Shares | Other | 2023-06-01 | |
| 2022-12-31 | $1,533,844 | 103,919 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $1,027,048 | 85,091 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $712,122 | 97,819 | Shares | Other | 2022-08-24 | |
| 2022-03-31 | $647,293 | 94,911 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $610,139 | 70,618 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $565,370 | 62,197 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $499,040 | 53,718 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $221,730 | 32,849 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $279,888 | 40,800 | Call | Other | 2021-02-16 | |
| 2020-12-31 | $1,073,363 | 156,467 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $859,982 | 153,843 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $212,568 | 40,800 | Call | Other | 2020-08-14 | |
| 2020-06-30 | $1,020,513 | 195,876 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $1,166,051 | 305,249 | Shares | Other | 2020-05-15 | |
| 2020-03-31 | $804,110 | 210,500 | Call | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||